Zarxio Injection, Solution
Product Images NDC 61314-318

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Zarxio (NDC 61314-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Safety Device (Zarxio 01)

FDA Label Image

Fig B (Zarxio 02)

FDA Label Image

Activated Do Not Use (Zarxio 03)

FDA Label Image

Ready To Use (Zarxio 04)

FDA Label Image

Front Injection Areas (Zarxio 05)

FDA Label Image

Back Injection Areas (Zarxio 06)

FDA Label Image

How To Remove Needle Cap (Zarxio 07)

FDA Label Image

Check Syringe For Air Bubble (Zarxio 08)

FDA Label Image

Positions (Zarxio 09)

FDA Label Image

How To Place Injection (Zarxio 10)

FDA Label Image

How To Fully Inject (Zarxio 11)

FDA Label Image

How To Remove Injection (Zarxio 12)

FDA Label Image

How To Lock Safety Device (Zarxio 13)

FDA Label Image

How To Dispose Of Safety Device (Zarxio 14)

FDA Label Image

300mcg Labal (Zarxio 15)

FDA Label Image

480mcg Label (Zarxio 16)

O Zarxio® is an injection medication with a concentration of 480 mcg/0.8 mL, and the active ingredient flgrastim-sndz. It is meant for single-use only and is used for stimulating the growth of white blood cells in patients with certain medical conditions. The medication should be used carefully in patients with latex allergies, as it contains natural rubber latex in its packaging. O Zarxio® is manufactured by Sandoz and is available only on a physician's prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.